Our latest press releases, media appearances and news commentary.
Scientists at the Alderley Park Lighthouse Lab in Cheshire processed their 6 millionth test over the festive period, the equivalent of providing tests for one in ten people in the UK.
Active Needle Technology, Xerion Healthcare and Medicines Discovery Catapult win funding to begin ground-breaking project.
Intelligent OMICS, Arctoris and Medicines Discovery Catapult test in silico pipeline for identifying new molecules for cancer treatment.
The Catapult Network launched today the 2019-2020 Annual Report – Creating the future through innovation: Recovery and Resilience.
Optibrium, Intellegens and Medicines Discovery Catapult combine their expertise in drug discovery and AI research.
Dr Sally Price, Head of Cell and Translational Science at Medicines Discovery Catapult (MDC) has been named in BioBeat’20 Movers & Shakers in BioBusiness 2020.
Today, the University of Exeter and Medicines Discovery Catapult (MDC) announce their strategic partnership to accelerate medicines Research & Development (R&D), creating value for the sector and enhancing translational skills.
Global mental health care company, COMPASS Pathways has joined the Psychiatry Consortium, bringing additional expertise and insights to the group.
The Alderley Park Lighthouse Lab in Cheshire, which plays a key role in the UK Government’s national COVID testing, last week processed its 4 millionth test since its launch at the start of the pandemic.
The national programme, to develop and progress start-up oncology projects, is being launched by Bruntwood SciTech at Alderley Park – the UK’s largest single site life science campus – with funding from Innovate UK and Cancer Research UK.
See how we can help support you with your next drug discovery project.
Speak to us